Preoperative anxiety and fear
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.2<=age<=6 years of age with CT or MRI, regardless of gender; 2. ASA score of I-II; 3.15.5 kg/m^2<=BMI<17kg/m^2; 4. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Children with respiratory tract management difficulties (modified Markov Level III); 2.Children with intellectual disabilities; 3.Allergic or contraindicated to dexmedetomidine hydrochloride and its drug components, midazolam or chloral hydrate; 4.The child was not suitable for nasal administration or could not receive nasal administration; 5.Other conditions deemed inappropriate by the investigator (e.g. fever, acute upper respiratory tract infection, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of sedation of dexmedetomidine hydrochloride nasal spray combined with midazolam oral liquid in children on MRI or CT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication rate, including (respiratory depression, hypoxemia, nausea, vomiting, etc.);Comparison of sedation success rate between two groups;Time of onset of sedation;The recovery time after examination; | — |
Countries
China
Contacts
People's Hospital of Leshan